Nuveen Portfolio holdings
Nuveen is the asset management arm of TIAA, a financial services group long focused on retirement savings for universities, other not-for-profit institutions and their employees. Nuveen manages all of TIAA's capital as well as money from outside investors, and began in Chicago in 1898 as John Nuveen & Company, an investment bank founded by John Nuveen Sr. to underwrite and sell municipal bonds. Its funds cover income, equity, real estate and real assets such as farmland and timberland, alongside private equity and private debt, and Nuveen and TIAA often invest their own money alongside clients. A private equity group led by Madison Dearborn Partners bought the firm in 2007, and it merged with TIAA in 2014.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$944M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$593M |
| 3 |
Sandisk
SNDK
|
+$559M |
| 4 |
Booking.com
BKNG
|
+$521M |
| 5 |
Micron Technology
MU
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.07B |
| 2 |
Microsoft
MSFT
|
+$1.51B |
| 3 |
NVIDIA
NVDA
|
+$1.18B |
| 4 |
Apple
AAPL
|
+$1.04B |
| 5 |
Broadcom
AVGO
|
+$949M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.08% |
| 2 | Financials | 10.73% |
| 3 | Industrials | 10.3% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Healthcare | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1901
James Hardie Industries
JHX
$17.4B
| $6.86M | ﹤0.01% |
261,879
+8,491
| +3% | +$187K |
2025 Q3
3 quarters
|
|
1902
DELISTED
AtaiBeckley Inc
ATAI
| $6.83M | ﹤0.01% |
1,295,262
+1,118,139
| +631% | +$4.71M |
2025 Q4
2 quarters
|
|
1903
Sarepta Therapeutics
SRPT
$1.85B
| $6.82M | ﹤0.01% |
379,295
+192,537
| +103% | +$3.64M |
2019 Q1
29 quarters
|
|
1904
Kodiak Sciences
KOD
$6.73B
| $6.81M | ﹤0.01% |
174,730
+79,438
| +83% | +$3.09M |
2019 Q2
28 quarters
|
|
1905
DELISTED
Select Medical
SEM
| $6.8M | ﹤0.01% |
411,906
+178,821
| +77% | +$2.95M |
2018 Q1
33 quarters
|
|
1906
Figure Technology Solutions
FIGR
$5.5B
| $6.78M | ﹤0.01% |
220,847
+145,734
| +194% | +$4.87M |
2025 Q4
2 quarters
|
|
1907
Ingevity
NGVT
$2.11B
| $6.77M | ﹤0.01% |
90,664
+7,430
| +9% | +$535K |
2016 Q4
38 quarters
|
|
1908
National Healthcare
NHC
$3.29B
| $6.75M | ﹤0.01% |
31,954
+4,487
| +16% | +$824K |
2019 Q2
28 quarters
|
|
1909
Starz Entertainment Corp
STRZ
$449M
| $6.75M | ﹤0.01% |
233,783
+155,574
| +199% | +$3.39M |
2025 Q2
4 quarters
|
|
1910
Nektar Therapeutics
NKTR
$1.29B
| $6.75M | ﹤0.01% |
+96,636
| New | +$7.07M |
2026 Q2
0 quarters
|
|
1911
Rezolute
RZLT
$374M
| $6.74M | ﹤0.01% |
1,295,209
+1,197,523
| +1,226% | +$4.45M |
2025 Q2
4 quarters
|
|
1912
Franklin BSP Realty Trust
FBRT
$484M
| $6.72M | ﹤0.01% |
825,882
+659,750
| +397% | +$5.73M |
2021 Q4
18 quarters
|
|
1913
IAMGOLD
IAG
$11.2B
| $6.71M | ﹤0.01% |
423,007
-10,318
| -2% | -$180K |
2023 Q4
10 quarters
|
|
1914
Hawkins
HWKN
$3.22B
| $6.71M | ﹤0.01% |
47,190
-14,721
| -24% | -$2.33M |
2019 Q2
28 quarters
|
|
1915
CNB Financial Corp
CCNE
$1.07B
| $6.7M | ﹤0.01% |
198,676
+91,940
| +86% | +$2.86M |
2019 Q2
28 quarters
|
|
1916
4D Molecular Therapeutics
FDMT
$689M
| $6.69M | ﹤0.01% |
503,071
-58,734
| -10% | -$572K |
2021 Q1
21 quarters
|
|
1917
Patrick Industries
PATK
$2.64B
| $6.67M | ﹤0.01% |
74,274
-238,243
| -76% | -$22.7M |
2019 Q1
29 quarters
|
|
1918
Cannae Holdings
CNNE
$765M
| $6.65M | ﹤0.01% |
462,082
-54,629
| -11% | -$743K |
2019 Q2
28 quarters
|
|
1919
Digi International
DGII
$2.55B
| $6.65M | ﹤0.01% |
88,714
+13,143
| +17% | +$815K |
2019 Q2
28 quarters
|
|
1920
Towne Bank
TOWN
$3.35B
| $6.64M | ﹤0.01% |
183,259
-280,996
| -61% | -$9.8M |
2019 Q2
28 quarters
|
|
1921
Carter Bankshares
CARE
$646M
| $6.64M | ﹤0.01% |
195,185
+148,266
| +316% | +$4.01M |
2019 Q2
28 quarters
|
|
1922
CMB.TECH NV
CMBT
$4.81B
| $6.63M | ﹤0.01% |
467,324
+376,202
| +413% | +$5.42M |
2025 Q3
3 quarters
|
|
1923
Walker & Dunlop
WD
$1.43B
| $6.61M | ﹤0.01% |
120,882
+10,033
| +9% | +$508K |
2019 Q2
28 quarters
|
|
1924
Organon & Co
OGN
$3.64B
| $6.59M | ﹤0.01% |
486,400
+17,469
| +4% | +$209K |
2021 Q2
20 quarters
|
|
1925
EPAM Systems
EPAM
$8B
| $6.58M | ﹤0.01% |
82,942
-127,849
| -61% | -$13.5M |
2019 Q2
28 quarters
|
|
Similar funds
Nuveen's Q2 2026 Portfolio in Review
As of Q2 2026, Nuveen held 3,870 positions worth $419B, up 14% from $369B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Nuveen's Q2 2026 filing shows 648 new, 1,897 increased, 998 reduced and 136 closed positions. Its largest new stake was Honeywell Aerospace: 2,688,848 shares worth $594M. The largest sale was Amazon, an estimated $2.07B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Nuveen's largest Q2 2026 buy was Honeywell Aerospace: 2,688,848 shares worth $594M.
- Nuveen added most to Tesla in Q2 2026, an estimated $944M increase.
- Nuveen's biggest Q2 2026 reduction was Amazon, cutting an estimated $2.07B.
- Nuveen fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, selling an estimated $393M.
- Nuveen's ten largest holdings make up 31% of its $419B portfolio in Q2 2026.
- Nuveen opened 648 new positions and closed 136 in Q2 2026.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $419B.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.